506 related articles for article (PubMed ID: 18230042)
1. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
Forsgren A; Riesbeck K; Janson H
Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
[TBL] [Abstract][Full Text] [Related]
2. Prevention of otitis media: now a reality?
Schuerman L; Borys D; Hoet B; Forsgren A; Prymula R
Vaccine; 2009 Sep; 27(42):5748-54. PubMed ID: 19666154
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of nontypeable Haemophilus influenzae protein D function reduces phosphorylcholine decoration, adherence to airway epithelial cells, and fitness in a chinchilla model of otitis media.
Johnson RW; McGillivary G; Denoël P; Poolman J; Bakaletz LO
Vaccine; 2011 Feb; 29(6):1211-21. PubMed ID: 21167861
[TBL] [Abstract][Full Text] [Related]
4. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.
Novotny LA; Jurcisek JA; Godfroid F; Poolman JT; Denoël PA; Bakaletz LO
Vaccine; 2006 May; 24(22):4804-11. PubMed ID: 16616975
[TBL] [Abstract][Full Text] [Related]
5. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
6. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.
Prymula R; Kriz P; Kaliskova E; Pascal T; Poolman J; Schuerman L
Vaccine; 2009 Dec; 28(1):71-8. PubMed ID: 19818722
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal conjugated vaccine: PHiD-CV.
Dinleyici EC; Yargic ZA
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1063-74. PubMed ID: 19883326
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
Khan MN; Kaur R; Pichichero ME
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
[TBL] [Abstract][Full Text] [Related]
10. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.
Prymula R; Chlibek R; Splino M; Kaliskova E; Kohl I; Lommel P; Schuerman L
Vaccine; 2008 Aug; 26(35):4563-70. PubMed ID: 18602724
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
12. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
Akkoyunlu M; Forsgren A
APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
[TBL] [Abstract][Full Text] [Related]
14. Nontypeable Haemophilus influenzae as a pathogen in children.
Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
17. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction.
Dagan R; Frasch C
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S63-5. PubMed ID: 19325448
[No Abstract] [Full Text] [Related]
19. Anamnestic immune response in 3- to 4-year-old children previously immunized with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as 2-dose or 3-dose priming and a booster dose in the first year of life.
Silfverdal SA; Skerlikova H; Zanova M; Papúchová D; Traskine M; Borys D; Schuerman L
Pediatr Infect Dis J; 2011 Sep; 30(9):e155-63. PubMed ID: 21572373
[TBL] [Abstract][Full Text] [Related]
20. Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine.
Hare KM; Smith-Vaughan HC; Leach AJ; Pizzutto SJ; McCallum GB; Chang AB
Vaccine; 2018 Mar; 36(13):1736-1742. PubMed ID: 29478754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
